AR and posterior cortical atrophy: Only cluster 4 in the mHSCP group showed increased neuroendocrine marker expression, aligning with previous findings that metastatic PCa, despite performs AR reactivity, undergoes some neuroendocrine transformation, reducing endocrine therapy effectiveness and advancing disease [32].